Clik here to view.
複合細胞療法による尿道狭窄治療で特許を取得
東京 （ビジネスワイヤ） — ポリマー足場材に埋め込み培養した患者自身の頬粘膜細胞を使って尿道狭窄を治療する方法が、日本で特許を取得しました。従来の方法での治療後に再狭窄が起こった患者に対し、この“Bees-Haus”（Buccal epithelium Expanded and Encapsulated in Scaffold‐Hybrid Approach to Urethral...
View ArticleClik here to view.
AVITA Therapeutics Provides Company Update and Preliminary Unaudited Results...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that...
View ArticleClik here to view.
BARDA to Initiate Procurement of the RECELL® System for Emergency Response...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that...
View ArticleClik here to view.
Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19...
CAMBRIDGE & WETHERBY, England Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce an expansion of its collaboration and license agreement...
View ArticleClik here to view.
Aroa Biosurgery’s Endoform® Platform Shown to Attract Stem Cells
AUCKLAND, New Zealand Soft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, ‘Aroa’ or the ‘Company’) has gained further validation for Endoform®, its flagship extracellular matrix...
View ArticleClik here to view.
苏爱康宣布Darinaparsin（外周T细胞淋巴瘤）关键2期临床研究结果为阳性
日本东京 (美国商业资讯)–苏爱康制药有限公司（东京证券交易所代码：4597， 总部：日本东京，总裁兼首席执行官：荒井好裕，以下简称“苏爱康”）,一家总部位于亚洲的专业制药公司，今日宣布苏爱康产品-02关键2期临床研究结果为阳性（一种抗癌新药，国际通用名为Darinaparsin）用于在亚洲地区治疗复发或难治性外周T细胞淋巴瘤治疗（以下简称“PTCL”）。 主要终点（抗肿瘤效应）已实现；...
View ArticleClik here to view.
ソレイジア・ファーマ: 開発品SP-02臨床試験結果に関するお知らせ
東京 （ビジネスワイヤ） — 当社は、開発品SP-02（新規抗がん剤、国際一般名：darinaparsin、一般名：ダリナパルシン）の、再発又は難治性の末梢性T細胞リンパ腫（以下、「PTCL」）を対象としたアジア国際共同第II相臨床試験（以下、「本試験」）につき、このたび以下の解析結果を得ましたのでお知らせいたします。 主要評価項目（SP-02抗腫瘍効果）を達成した...
View ArticleClik here to view.
Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for...
MADISON, Wis. Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s...
View ArticleClik here to view.
Gunze Provides Biodegradable Scaffolds for TEVG Clinical Trial to Be...
OSAKA, Japan Gunze Limited (Headquarters: Osaka, Japan, President: Atsushi Hirochi) [TOKYO:3002] is pleased to announce that Gunze’s biodegradable scaffolds are being provided to the Abigail Wexner...
View ArticleClik here to view.
Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific...
HANGZHOU, China Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced the expansion of its Scientific Advisory Board to include a...
View ArticleClik here to view.
EasyCOV, the Virological Saliva Test for COVID19 Confirms Its Excellent...
PARIS EasyCOV, a virological saliva detection test for COVID19, has shown a sensitivity of 88% and a specificity 99% during a clinical trial performed at the testing center operated by the teaching...
View ArticleClik here to view.
Qihan Biotech Unveils its Program to Develop Immunologically Privileged Human...
HANGZHOU, China Qihan Biotech, a leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, today disclosed the initiation of a program to create...
View ArticleClik here to view.
Kasturba Medical College, India Wins XV Fujio Cup Quiz in NCRM NICHE 2020
TOKYO Sufyan Ibrahim and Himanshu Yashavanthi Nagesh of Kasturba Medical College, India, won the prestigious Fujio Cup Quiz (FCQ), an active knowledge gaining academic event of NCRM NICHE 2020, on...
View ArticleClik here to view.
印度Kasturba医学院在NCRM NICHE 2020上赢得第15届Fujio Cup Quiz
东京 (美国商业资讯)– 来自印度Kasturba医学院(Kasturba Medical College)的Sufyan Ibrahim和Himanshu Yashavanthi Nagesh在著名的Fujio Cup Quiz (FCQ)中获胜。FCQ是2020年日印再生医学中心NICHE大会(NCRM NICHE...
View ArticleClik here to view.
Clik here to view.
IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal...
PUNE, India & NEW YORK Today, IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges, and Serum Institute of India Pvt. Ltd., a leading...
View ArticleClik here to view.
Patients with Severe Paralysis Use Stentrode Brain-Computer Interface to...
SAN FRANCISCO & NEW YORK CITY & MELBOURNE Synchron, a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the...
View ArticleClik here to view.
Heartseed Named “Healthcare Company of the Year 2020” by Healthcare Insights...
TOKYO Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocyte spheroids for the treatment of heart failure (hereinafter HF), today announced...
View ArticleClik here to view.
Veristat Named Top Patient Recruitment Company 2020 by Pharma Tech Outlook
SOUTHBOROUGH, Mass. Veristat, a global clinical research organization, was named among the Top Patient Recruitment Companies of 2020 by Pharma Tech Outlook. With over 26 years’ experience partnering...
View ArticleClik here to view.
Complimentary Ticket to Join YAFO ACCESS CHINA Forum 2021
SHANGHAI YAFO Life Science and BioToChina.org announced the schedule for ACCESS CHINA Forum 2021 (January 4th - 22nd). As the largest China corporate access event during the JPM Conference weeks,...
View Article